Premier Vision Optical Laboratory
Specialty · Migraine & Light Sensitivity

Avulux Migraine Lenses

In August 2026 the FDA granted Avulux De Novo marketing authorization — creating the first FDA-recognized lens classification for migraine-associated light sensitivity. It's a precision multi-band notch filter that blocks light at 480 nm and 590 nm — the wavelengths shown to worsen migraine — while letting the rest of the visible spectrum through.
  • First and only FDA-authorized migraine lens
  • Targets 480 nm and 590 nm specifically
  • Looks like a light sunglass — wearable all day
  • Indoor and outdoor use
Patient wearing Avulux glasses at her eye care provider's office

IMAGE: AVULUX

1 in 7 patients lives with migraine

Your next growth category is already in your exam chair

Patients describe the problem before they ever name it: squinting under exam lights, dimming their screens, dreading the drive home. Up to 90% of people with migraine experience light sensitivity — and Avulux gives your practice an FDA-authorized answer you can dispense today.

90%

of people living with migraine experience light sensitivity

96%

of wearers agreed Avulux reduced the impact of light sensitivity

90%

of wearers agreed digital screens were more comfortable

Why it works for your practice

A premium specialty category for patients you're already seeing.

Premium private-pay revenue

No vision-plan fee schedules or write-downs. Patients who've tried everything are motivated to buy a real option.

Fits your existing workflow

No equipment or new process. Any patient, any Rx — single vision, progressive, or plano — ordered on your normal Premier Vision ticket.

Keeps the sale in-house

Instead of patients buying generic tints online, your practice dispenses an FDA-authorized device.

90-day satisfaction guarantee

Dispense with confidence — Avulux backs the patient experience for 90 days.

Why we carry Avulux

A genuinely differentiated specialty lens for a patient population most offices have nothing for.

Clinically meaningful

Independent, peer-reviewed research shows reduced migraine impact for many patients who wear Avulux during attacks.

Helps light sensitivity

Also valuable for patients with general photophobia, post-concussion syndrome, or chronic light triggers — not just migraine sufferers.

Indoor and outdoor

Subtle enough to wear at the desk, dark enough to be useful outside. Patients aren't switching glasses all day.

Prescription-ready

We surface Avulux with your patient's prescription and finish into their frame here in our lab.

FDA De Novo authorized

August 2026: the FDA created a new device classification for Avulux — the first and only authorized lens for migraine-associated light sensitivity.

High-margin specialty

Patients with chronic migraines have usually tried everything. They're motivated buyers when a real option exists.

The question we get most

Avulux vs. FL-41 and other light sensitivity lenses

FL-41 and most tints are broad filters — they knock down a wide swath of the spectrum more or less evenly, which is why they read as a rose or amber wash. Avulux is a patented multi-band notch filter: it drops hard at the specific wavelengths shown to trigger and worsen migraine and leaves the rest of the spectrum alone.

Spectral transmission chart comparing Avulux migraine and light sensitivity lenses against FL-41 across 380 to 780 nanometers
Transmission curves, 380–780 nm. Chart: Avulux

Deep notches at 480 nm and 590 nm

Avulux (teal) falls to near zero at the high-blue and red/amber bands implicated in migraine. FL-41 (pink) never dips below roughly 45% anywhere in that range — it dims those wavelengths, but doesn't remove them.

Green light stays open

Between the notches Avulux climbs back up, passing the soothing green band. That's what keeps color perception usable and makes the lens wearable at a desk all day rather than only during an attack.

Precision, not a tint recipe

"FL-41" is a color family, and it varies widely lab to lab. Avulux is a patented, manufactured filter with a fixed curve — every pair performs the same. That consistency is a large part of what the FDA reviewed.

An FDA-recognized classification of its own

De Novo authorization (August 2026) is reserved for first-of-their-kind devices with no existing equivalent. It covers episodic migraine patients 12 and older and is backed by randomized controlled trials plus 50,000+ wearers. No FL-41 lens carries anything comparable. Read the announcement.

FDA De Novo indication

Indicated to decrease the impact of light sensitivity in patients diagnosed with episodic migraine, ages 12 and older. Use alongside usual care.

Both have a place. We tint our own Premier FL-41 to measured spec for patients who want a general light-sensitivity or screen-comfort lens at a lower price point. When the diagnosis is migraine, Avulux is the one with the clinical evidence and the FDA authorization behind it.

Avulux wearer in natural daylight
Musician performing live wearing Avulux glasses
Avulux lens — multi-band notch filter
Pair of Avulux migraine glasses
Avulux migraine and light sensitivity lifestyle banner

Imagery courtesy of Avulux

Start dispensing Avulux in two steps

1

Become an authorized Avulux provider

Sign up with Avulux to get listed on their Provider Locator, team training, a dedicated Regional Brand Rep, and ongoing marketing support.

2

Order through Premier Vision

Send Avulux on your normal lab ticket. We surface to prescription and finish into the patient's frame.

Help your migraine patients see a difference

Questions about becoming a provider or ordering? We'll help you get started.